Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary
This executive summary presents in brief the current evidence assessed in the clinical practice guideline prepared by the Canadian Hypertensive Disorders of Pregnancy Working Group and published by Pregnancy Hypertension (http://www.pregnancyhypertension.org/article/S2210-7789(14)00004-X/fulltext) t...
Saved in:
| Published in | Journal of obstetrics and gynaecology Canada Vol. 36; no. 5; pp. 416 - 438 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier Inc
01.05.2014
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | This executive summary presents in brief the current evidence assessed in the clinical practice guideline prepared by the Canadian Hypertensive Disorders of Pregnancy Working Group and published by Pregnancy Hypertension (http://www.pregnancyhypertension.org/article/S2210-7789(14)00004-X/fulltext) to provide a reasonable approach to the diagnosis, evaluation, and treatment of the hypertensive disorders of pregnancy.
Published literature was retrieved through searches of Medline, CINAHL, and The Cochrane Library in March 2012 using appropriate controlled vocabulary (e.g., pregnancy, hypertension, pre-eclampsia, pregnancy toxemias) and key words (e.g., diagnosis, evaluation, classification, prediction, prevention, prognosis, treatment, postpartum follow-up). Results were restricted to systematic reviews, randomized control trials, controlled clinical trials, and observational studies published in French or English between January 2006 and February 2012. Searches were updated on a regular basis and incorporated in the guideline to September 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies.
The quality of evidence in the guideline summarized here was rated using the criteria described in the Report of the Canadian Task Force on Preventative Health Care (Table 1). |
|---|---|
| AbstractList | Abstract Objective This executive summary presents in brief the current evidence assessed in the clinical practice guideline prepared by the Canadian Hypertensive Disorders of Pregnancy Working Group and published by Pregnancy Hypertension ( http://www.pregnancyhypertension.org/article/S2210-7789(14)00004-X/fulltext ) to provide a reasonable approach to the diagnosis, evaluation, and treatment of the hypertensive disorders of pregnancy. Evidence Published literature was retrieved through searches of Medline, CINAHL, and The Cochrane Library in March 2012 using appropriate controlled vocabulary (e.g., pregnancy, hypertension, pre-eclampsia, pregnancy toxemias) and key words (e.g., diagnosis, evaluation, classification, prediction, prevention, prognosis, treatment, postpartum follow-up). Results were restricted to systematic reviews, randomized control trials, controlled clinical trials, and observational studies published in French or English between January 2006 and February 2012. Searches were updated on a regular basis and incorporated in the guideline to September 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. Values The quality of evidence in the guideline summarized here was rated using the criteria described in the Report of the Canadian Task Force on Preventative Health Care (Table 1). This executive summary presents in brief the current evidence assessed in the clinical practice guideline prepared by the Canadian Hypertensive Disorders of Pregnancy Working Group and published by Pregnancy Hypertension (http://www.pregnancyhypertension.org/article/S2210-7789(14)00004-X/fulltext) to provide a reasonable approach to the diagnosis, evaluation, and treatment of the hypertensive disorders of pregnancy.OBJECTIVEThis executive summary presents in brief the current evidence assessed in the clinical practice guideline prepared by the Canadian Hypertensive Disorders of Pregnancy Working Group and published by Pregnancy Hypertension (http://www.pregnancyhypertension.org/article/S2210-7789(14)00004-X/fulltext) to provide a reasonable approach to the diagnosis, evaluation, and treatment of the hypertensive disorders of pregnancy.Published literature was retrieved through searches of Medline, CINAHL, and The Cochrane Library in March 2012 using appropriate controlled vocabulary (e.g., pregnancy, hypertension, pre-eclampsia, pregnancy toxemias) and key words (e.g., diagnosis, evaluation, classification, prediction, prevention, prognosis, treatment, postpartum follow-up). Results were restricted to systematic reviews, randomized control trials, controlled clinical trials, and observational studies published in French or English between January 2006 and February 2012. Searches were updated on a regular basis and incorporated in the guideline to September 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies.EVIDENCEPublished literature was retrieved through searches of Medline, CINAHL, and The Cochrane Library in March 2012 using appropriate controlled vocabulary (e.g., pregnancy, hypertension, pre-eclampsia, pregnancy toxemias) and key words (e.g., diagnosis, evaluation, classification, prediction, prevention, prognosis, treatment, postpartum follow-up). Results were restricted to systematic reviews, randomized control trials, controlled clinical trials, and observational studies published in French or English between January 2006 and February 2012. Searches were updated on a regular basis and incorporated in the guideline to September 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies.The quality of evidence in the guideline summarized here was rated using the criteria described in the Report of the Canadian Task Force on Preventative Health Care (Table 1).VALUESThe quality of evidence in the guideline summarized here was rated using the criteria described in the Report of the Canadian Task Force on Preventative Health Care (Table 1). This executive summary presents in brief the current evidence assessed in the clinical practice guideline prepared by the Canadian Hypertensive Disorders of Pregnancy Working Group and published by Pregnancy Hypertension (http://www.pregnancyhypertension.org/article/S2210-7789(14)00004-X/fulltext) to provide a reasonable approach to the diagnosis, evaluation, and treatment of the hypertensive disorders of pregnancy. Published literature was retrieved through searches of Medline, CINAHL, and The Cochrane Library in March 2012 using appropriate controlled vocabulary (e.g., pregnancy, hypertension, pre-eclampsia, pregnancy toxemias) and key words (e.g., diagnosis, evaluation, classification, prediction, prevention, prognosis, treatment, postpartum follow-up). Results were restricted to systematic reviews, randomized control trials, controlled clinical trials, and observational studies published in French or English between January 2006 and February 2012. Searches were updated on a regular basis and incorporated in the guideline to September 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. The quality of evidence in the guideline summarized here was rated using the criteria described in the Report of the Canadian Task Force on Preventative Health Care (Table 1). This executive summary presents in brief the current evidence assessed in the clinical practice guideline prepared by the Canadian Hypertensive Disorders of Pregnancy Working Group and published by Pregnancy Hypertension (http://www.pregnancyhypertension.org/article/S2210-7789(14)00004-X/fulltext) to provide a reasonable approach to the diagnosis, evaluation, and treatment of the hypertensive disorders of pregnancy. Published literature was retrieved through searches of Medline, CINAHL, and The Cochrane Library in March 2012 using appropriate controlled vocabulary (e.g., pregnancy, hypertension, pre-eclampsia, pregnancy toxemias) and key words (e.g., diagnosis, evaluation, classification, prediction, prevention, prognosis, treatment, postpartum follow-up). Results were restricted to systematic reviews, randomized control trials, controlled clinical trials, and observational studies published in French or English between January 2006 and February 2012. Searches were updated on a regular basis and incorporated in the guideline to September 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. The quality of evidence in the guideline summarized here was rated using the criteria described in the Report of the Canadian Task Force on Preventative Health Care (Table 1). |
| Author | Gruslin, Andrée Logan, Alexander G. Sebbag, Ilana Pels, Anouk Audibert, Francois Magee, Laura A. von Dadelszen, Peter Leduc, Line Douglas, Myrtle Joanne Côté, Anne-Marie Bujold, Emmanuel Hutcheon, Jennifer Koren, Gideon Rey, Evelyne MacDonell, Karen L. Firoz, Tabassum Gibson, Paul Eastabrook, Genevieve Lange, Ian Helewa, Michael Moutquin, Jean-Marie |
| Author_xml | – sequence: 1 givenname: Laura A. surname: Magee fullname: Magee, Laura A. organization: Vancouver BC – sequence: 2 givenname: Anouk surname: Pels fullname: Pels, Anouk organization: Amsterdam, the Netherlands – sequence: 3 givenname: Michael surname: Helewa fullname: Helewa, Michael organization: Winnipeg MB – sequence: 4 givenname: Evelyne surname: Rey fullname: Rey, Evelyne organization: Montreal QC – sequence: 5 givenname: Peter surname: von Dadelszen fullname: von Dadelszen, Peter organization: Vancouver BC – sequence: 6 givenname: Laura A. surname: Magee fullname: Magee, Laura A. organization: Vancouver BC – sequence: 7 givenname: Francois surname: Audibert fullname: Audibert, Francois organization: Montreal QC – sequence: 8 givenname: Emmanuel surname: Bujold fullname: Bujold, Emmanuel organization: Quebec QC – sequence: 9 givenname: Anne-Marie surname: Côté fullname: Côté, Anne-Marie organization: Sherbrooke QC – sequence: 10 givenname: Myrtle Joanne surname: Douglas fullname: Douglas, Myrtle Joanne organization: Vancouver BC – sequence: 11 givenname: Genevieve surname: Eastabrook fullname: Eastabrook, Genevieve organization: London ON – sequence: 12 givenname: Tabassum surname: Firoz fullname: Firoz, Tabassum organization: Vancouver BC – sequence: 13 givenname: Paul surname: Gibson fullname: Gibson, Paul organization: Calgary AB – sequence: 14 givenname: Andrée surname: Gruslin fullname: Gruslin, Andrée organization: Ottawa ON – sequence: 15 givenname: Jennifer surname: Hutcheon fullname: Hutcheon, Jennifer organization: Vancouver BC – sequence: 16 givenname: Gideon surname: Koren fullname: Koren, Gideon organization: Toronto ON – sequence: 17 givenname: Ian surname: Lange fullname: Lange, Ian organization: Calgary AB – sequence: 18 givenname: Line surname: Leduc fullname: Leduc, Line organization: Montreal QC – sequence: 19 givenname: Alexander G. surname: Logan fullname: Logan, Alexander G. organization: Toronto ON – sequence: 20 givenname: Karen L. surname: MacDonell fullname: MacDonell, Karen L. organization: Vancouver BC – sequence: 21 givenname: Jean-Marie surname: Moutquin fullname: Moutquin, Jean-Marie organization: Sherbrooke QC – sequence: 22 givenname: Ilana surname: Sebbag fullname: Sebbag, Ilana organization: Vancouver BC |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24927294$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkc1u1DAURr0ooj_wCKAsi9SAncR2AioItQNFKgKpsLacm-vBJbEH2xl13r7JTMuiEiorS_b3HV-de0j2nHdIyAtGXzPKxJsrJinLCybKY8ZflZTXdU73yMHf631yGOM1pVyWsnlK9ouqKWTRVAcEzq1eOh9tPMkWa92POlnvTjLtuuyrdnqJA7qUeZOlX5hdbFYYErpo15id2-hDhyHOr98DLp12sHmbLW4QxjQnrsZh0GHzjDwxuo_4_O48Ij8_LX6cXeSX3z5_Oft4mUPFeco7WUFjBGsroaUwDRMtrbhhEiqmC4mlAdAVbzltRdkWCKw2dEqbDtHUnJVH5HjHXQX_Z8SY1GAjYN9rh36MivFSiLqUopiiL--iYztgp1bBzpOqezFT4N0uAMHHGNAosGnrJgVte8WomtWrrXo1O57waqte0anNH7TvP3is92HXw0nT2mJQESw6wM4GhKQ6bx8lvH9AgN46C7r_jRuM134MbtqBYioWiu4gM2NyMxNmwOm_Af8xwC2O7cWI |
| CitedBy_id | crossref_primary_10_1016_j_ajog_2021_04_261 crossref_primary_10_2147_IJWH_S260894 crossref_primary_10_1016_j_preghy_2018_01_005 crossref_primary_10_1371_journal_pone_0302019 crossref_primary_10_61678_bursamed_1394794 crossref_primary_10_7326_M18_0338 crossref_primary_10_1016_j_jogc_2017_08_047 crossref_primary_10_1177_1747493017743801 crossref_primary_10_1186_s12884_021_03938_8 crossref_primary_10_1177_1747493018786617 crossref_primary_10_1080_10641955_2019_1590718 crossref_primary_10_1016_j_ajog_2022_06_038 crossref_primary_10_1016_j_preghy_2017_07_145 crossref_primary_10_1007_s12170_022_00705_y crossref_primary_10_1016_j_preghy_2015_11_004 crossref_primary_10_1080_10641955_2016_1228957 crossref_primary_10_1016_j_peptides_2019_170132 crossref_primary_10_1016_j_preghy_2017_11_005 crossref_primary_10_1016_j_metabol_2021_154794 crossref_primary_10_1111_1471_0528_17430 crossref_primary_10_1007_s13205_019_2030_z crossref_primary_10_1097_AOG_0000000000004506 crossref_primary_10_1097_HJH_0000000000001450 crossref_primary_10_1111_1471_0528_16691 crossref_primary_10_1002_jcp_29286 crossref_primary_10_1016_j_jogc_2016_05_001 crossref_primary_10_1038_s41440_020_00544_7 crossref_primary_10_1007_s13224_021_01610_x crossref_primary_10_1186_s10020_020_00253_4 crossref_primary_10_20473_jn_v17i1_35036 crossref_primary_10_1016_j_ajog_2016_09_076 crossref_primary_10_1111_jog_13210 crossref_primary_10_1186_s12884_022_04827_4 crossref_primary_10_3390_ijerph182211783 crossref_primary_10_1017_S2040174418000478 crossref_primary_10_1111_aogs_14199 crossref_primary_10_1186_s12905_024_03436_x crossref_primary_10_1177_1753944715597622 crossref_primary_10_4239_wjd_v10_i7_396 crossref_primary_10_1016_j_jogn_2019_07_003 crossref_primary_10_1016_j_jrras_2018_02_001 crossref_primary_10_1515_labmed_2018_0185 crossref_primary_10_1371_journal_pone_0180874 crossref_primary_10_1002_uog_19076 crossref_primary_10_1016_j_jogc_2021_05_004 crossref_primary_10_2174_1574886314666190121144711 crossref_primary_10_1016_j_preghy_2017_07_139 crossref_primary_10_1016_j_jogc_2016_05_005 crossref_primary_10_1016_j_preghy_2018_05_004 crossref_primary_10_1097_OGX_0000000000000942 crossref_primary_10_1007_s00404_022_06864_y crossref_primary_10_1080_14767058_2018_1489531 crossref_primary_10_4103_IJO_IJO_2995_22 crossref_primary_10_3892_etm_2017_4212 crossref_primary_10_1016_j_jogc_2018_02_004 crossref_primary_10_1186_s12964_022_00853_z crossref_primary_10_1016_S1701_2163_15_30532_6 crossref_primary_10_1007_s10995_023_03628_1 crossref_primary_10_1007_s00129_018_4321_6 crossref_primary_10_1016_j_midw_2024_104116 crossref_primary_10_1016_j_preghy_2018_12_004 crossref_primary_10_21320_1818_474X_2020_1_41_52 crossref_primary_10_1007_s40267_014_0148_y crossref_primary_10_1016_j_ajog_2021_08_027 crossref_primary_10_1016_j_jmpt_2021_03_002 crossref_primary_10_1016_j_mehy_2018_11_011 crossref_primary_10_1080_01443615_2019_1572727 crossref_primary_10_1136_heartjnl_2021_319606 crossref_primary_10_3390_jcm8101625 crossref_primary_10_1111_aogs_12915 crossref_primary_10_1161_CIRCIMAGING_116_004888 crossref_primary_10_2174_1573402114666180516131832 crossref_primary_10_1053_j_ajkd_2016_10_030 crossref_primary_10_1016_j_bpobgyn_2015_02_005 crossref_primary_10_1111_jog_13230 crossref_primary_10_1097_AOG_0000000000004720 crossref_primary_10_1016_j_preghy_2017_10_002 crossref_primary_10_1038_srep38030 crossref_primary_10_1111_trf_16003 crossref_primary_10_3892_etm_2019_7184 crossref_primary_10_1161_HYPERTENSIONAHA_117_10606 crossref_primary_10_9778_cmajo_20160092 crossref_primary_10_4103_abr_abr_93_20 crossref_primary_10_1016_j_jogc_2020_03_016 crossref_primary_10_1016_j_preghy_2018_01_003 crossref_primary_10_3897_folmed_64_e64741 crossref_primary_10_1038_hr_2014_128 crossref_primary_10_3390_jcm11020452 crossref_primary_10_3897_pharmacia_71_e122471 crossref_primary_10_1016_j_nursi_2017_07_014 crossref_primary_10_1371_journal_pone_0113715 crossref_primary_10_1016_j_ejogrb_2022_12_032 crossref_primary_10_1080_09513590_2019_1658188 crossref_primary_10_1152_ajpregu_00040_2018 crossref_primary_10_1097_OGX_0000000000000510 crossref_primary_10_1002_jca_21899 crossref_primary_10_1016_j_placenta_2016_03_010 crossref_primary_10_1016_j_ahj_2024_03_014 crossref_primary_10_4102_safp_v62i1_5095 crossref_primary_10_1056_NEJMoa1404595 crossref_primary_10_1002_uog_14799 crossref_primary_10_7326_aimcc_2024_1013 crossref_primary_10_1016_j_preghy_2018_02_013 crossref_primary_10_1016_j_bpobgyn_2015_04_001 crossref_primary_10_1080_10641955_2020_1866008 crossref_primary_10_1016_j_jacc_2018_02_033 crossref_primary_10_3390_diagnostics14131347 crossref_primary_10_1016_j_jri_2025_104426 crossref_primary_10_1016_j_phanu_2021_100251 crossref_primary_10_1111_anae_15322 crossref_primary_10_1016_j_tacc_2016_05_004 crossref_primary_10_1016_j_jogc_2019_03_026 crossref_primary_10_1111_ajo_13460 crossref_primary_10_1007_s10517_016_3259_8 crossref_primary_10_1111_bjh_13209 crossref_primary_10_15829_1560_4071_2020_4181 crossref_primary_10_3390_children10050826 crossref_primary_10_1016_j_jogc_2019_03_022 crossref_primary_10_1016_j_cjca_2021_09_002 crossref_primary_10_1002_uog_17373 crossref_primary_10_1016_j_bjane_2021_02_052 crossref_primary_10_1136_bjsports_2020_102042 crossref_primary_10_1080_14656566_2019_1594773 crossref_primary_10_1016_j_eurox_2022_100141 crossref_primary_10_1016_j_rpth_2023_100075 crossref_primary_10_1080_1744666X_2022_2074399 crossref_primary_10_1016_j_ajog_2015_07_027 crossref_primary_10_1038_jp_2016_133 crossref_primary_10_1093_ajcn_nqab172 crossref_primary_10_1177_1933719116669053 crossref_primary_10_1016_j_clinbiochem_2020_10_002 crossref_primary_10_1016_j_placenta_2020_08_012 crossref_primary_10_1097_JCN_0000000000001085 crossref_primary_10_2196_mhealth_9671 crossref_primary_10_3390_jcm10133000 crossref_primary_10_1186_s12884_022_05325_3 crossref_primary_10_11603_24116_4944_2023_1_13941 crossref_primary_10_5005_jp_journals_10009_1922 crossref_primary_10_1016_j_ajog_2016_11_1043 crossref_primary_10_1080_14767058_2018_1548598 crossref_primary_10_17749_2313_7347_ob_gyn_rep_2022_324 crossref_primary_10_1016_j_jogc_2019_03_008 crossref_primary_10_1007_s11906_014_0454_8 crossref_primary_10_1016_j_placenta_2020_10_004 crossref_primary_10_3109_14767058_2015_1121229 crossref_primary_10_3390_ijms160818454 crossref_primary_10_1016_j_ajog_2016_10_016 crossref_primary_10_1055_s_0040_1709696 crossref_primary_10_1080_14767058_2023_2200879 crossref_primary_10_1177_1753495X221074613 crossref_primary_10_1080_14767058_2018_1547703 crossref_primary_10_1093_ajh_hpy069 crossref_primary_10_3889_oamjms_2016_025 crossref_primary_10_1007_s11906_022_01230_4 crossref_primary_10_1007_s12630_015_0375_2 crossref_primary_10_15406_ogij_2017_06_00229 crossref_primary_10_1038_s41440_023_01208_y crossref_primary_10_17116_rosakush20212106132 crossref_primary_10_1080_14767058_2019_1704246 crossref_primary_10_1186_s12978_016_0197_x crossref_primary_10_1016_S2666_7568_22_00292_6 crossref_primary_10_1186_s12978_019_0674_0 crossref_primary_10_1016_S1889_1837_18_30075_8 crossref_primary_10_1371_journal_pone_0175914 crossref_primary_10_13181_mji_v28i1_1795 crossref_primary_10_1002_jcph_1685 crossref_primary_10_1016_j_preghy_2017_11_003 crossref_primary_10_1111_ijlh_12796 crossref_primary_10_15446_revfacmed_v65n1Sup_59525 crossref_primary_10_1016_j_placenta_2020_04_003 crossref_primary_10_1002_ijgo_14182 crossref_primary_10_1080_10641955_2019_1638396 crossref_primary_10_3390_s24103151 crossref_primary_10_1016_j_jogc_2019_08_035 crossref_primary_10_1080_14767058_2017_1399117 crossref_primary_10_1177_2050312119843700 crossref_primary_10_1515_jpm_2021_0015 crossref_primary_10_1515_jpm_2021_0499 crossref_primary_10_1055_a_2497_8104 crossref_primary_10_1080_14767058_2020_1716330 crossref_primary_10_1016_j_fmc_2022_11_003 crossref_primary_10_1016_j_jogc_2024_102581 crossref_primary_10_1136_bmjopen_2019_035145 crossref_primary_10_1161_JAHA_121_023694 crossref_primary_10_1111_jmwh_12725 crossref_primary_10_1152_ajpheart_00578_2019 crossref_primary_10_1111_jog_14017 crossref_primary_10_1016_j_ajog_2017_12_004 crossref_primary_10_1080_14656566_2019_1570134 crossref_primary_10_3109_09513590_2015_1115833 crossref_primary_10_1016_j_molmet_2017_06_016 crossref_primary_10_1053_j_ajkd_2014_11_007 crossref_primary_10_3390_biology14030240 crossref_primary_10_1016_j_crwh_2021_e00379 crossref_primary_10_1186_s12884_016_1174_7 crossref_primary_10_1186_s12884_022_05055_6 crossref_primary_10_1159_000487301 crossref_primary_10_2139_ssrn_4060722 crossref_primary_10_3892_etm_2018_6893 crossref_primary_10_1016_j_preghy_2020_01_012 crossref_primary_10_1590_1982_0194201900038 crossref_primary_10_1016_j_ajog_2021_11_1366 crossref_primary_10_1055_s_0039_1687859 crossref_primary_10_1080_14767058_2016_1242122 crossref_primary_10_1016_j_dld_2015_11_004 crossref_primary_10_1016_j_jtha_2023_03_014 crossref_primary_10_1177_1753495X241275847 crossref_primary_10_1016_j_rpth_2024_102430 crossref_primary_10_1097_01_NURSE_0000504692_56573_ae crossref_primary_10_1016_j_hipert_2016_06_002 crossref_primary_10_1055_s_0041_1727215 crossref_primary_10_1038_s41440_022_00853_z crossref_primary_10_1177_0961203318770536 crossref_primary_10_12968_bjom_2018_26_7_451 crossref_primary_10_7759_cureus_36909 crossref_primary_10_1080_14767058_2019_1572737 crossref_primary_10_1177_2010105817698160 crossref_primary_10_1016_j_ajog_2020_04_031 crossref_primary_10_1038_s41598_018_21492_w crossref_primary_10_1042_CS20150678 crossref_primary_10_1016_j_preghy_2020_04_015 crossref_primary_10_1016_j_preghy_2018_06_009 crossref_primary_10_1080_10641955_2024_2329068 crossref_primary_10_1016_j_jogc_2019_06_017 crossref_primary_10_1016_j_preghy_2018_06_005 crossref_primary_10_3390_cimb44070203 crossref_primary_10_1111_ppe_13003 crossref_primary_10_1016_j_cjca_2021_08_007 crossref_primary_10_1053_j_ajkd_2021_07_017 crossref_primary_10_1080_14767058_2021_1949703 crossref_primary_10_1016_j_preghy_2021_03_002 crossref_primary_10_1093_pch_pxaa091 crossref_primary_10_1007_s12630_017_0867_3 crossref_primary_10_1007_s11936_018_0653_8 crossref_primary_10_1007_s11306_019_1600_8 crossref_primary_10_1016_j_reprotox_2024_108574 crossref_primary_10_1556_650_2022_32427 crossref_primary_10_37939_jrmc_v27i2_1902 crossref_primary_10_1016_S1701_2163_15_30146_8 crossref_primary_10_3389_fcvm_2024_1471199 crossref_primary_10_1111_aogs_14378 crossref_primary_10_3390_ijms22083904 crossref_primary_10_1016_j_cjca_2021_08_020 crossref_primary_10_1017_cem_2015_76 crossref_primary_10_1186_s12916_023_03167_0 crossref_primary_10_1016_j_jogc_2018_11_011 crossref_primary_10_1186_s12884_014_0390_2 crossref_primary_10_1590_2175_8239_jbn_2020_0055 crossref_primary_10_3389_fpubh_2020_00086 crossref_primary_10_1016_j_jogc_2024_102665 crossref_primary_10_1517_14740338_2015_998197 crossref_primary_10_1016_j_ajog_2022_01_026 crossref_primary_10_1371_journal_pone_0124684 crossref_primary_10_1097_01_NAJ_0000605352_84144_a2 crossref_primary_10_1016_j_jash_2017_12_003 crossref_primary_10_3390_diagnostics11040661 crossref_primary_10_1111_anec_12769 crossref_primary_10_1002_uog_20118 crossref_primary_10_1016_j_preghy_2023_09_005 crossref_primary_10_3399_BJGPO_2022_0070 crossref_primary_10_3389_fgene_2023_1248088 crossref_primary_10_1007_s10517_017_3812_0 crossref_primary_10_1016_j_preghy_2020_07_006 crossref_primary_10_3390_cells11081256 crossref_primary_10_1002_ijgo_14345 crossref_primary_10_1177_1753495X18793484 crossref_primary_10_1111_aogs_14149 crossref_primary_10_5646_ch_2025_31_e1 crossref_primary_10_1186_s12884_023_06099_y crossref_primary_10_1016_j_jogc_2020_06_011 crossref_primary_10_3390_jcm11144185 crossref_primary_10_1016_j_preghy_2019_02_007 crossref_primary_10_1016_S1701_2163_15_30533_8 crossref_primary_10_1016_j_ajog_2021_01_018 crossref_primary_10_7717_peerj_9880 crossref_primary_10_1016_j_ajog_2020_08_008 crossref_primary_10_1016_j_biopsycho_2016_02_002 crossref_primary_10_1016_j_sagf_2022_06_011 crossref_primary_10_1016_j_cjco_2023_12_015 crossref_primary_10_3390_ijerph19169961 crossref_primary_10_1016_j_cll_2016_01_013 crossref_primary_10_1016_S1701_2163_15_30145_6 crossref_primary_10_1155_2019_6270187 crossref_primary_10_3945_an_115_010736 crossref_primary_10_1016_j_jogc_2017_01_009 crossref_primary_10_1080_14767058_2017_1402878 crossref_primary_10_1136_bjsports_2016_096218 crossref_primary_10_1007_s15013_016_0849_5 crossref_primary_10_1016_j_ijmedinf_2024_105645 crossref_primary_10_1016_j_cjca_2019_04_004 crossref_primary_10_1016_j_jogc_2020_06_024 crossref_primary_10_1038_s41371_020_0312_x crossref_primary_10_1111_jch_14893 crossref_primary_10_1371_journal_pone_0215807 crossref_primary_10_15406_ogij_2015_02_00034 crossref_primary_10_3390_medicina58121772 crossref_primary_10_3892_etm_2019_7286 crossref_primary_10_1016_j_placenta_2016_05_002 crossref_primary_10_1155_2019_2675101 crossref_primary_10_1186_s13690_020_00423_0 crossref_primary_10_1007_s00011_016_0953_y crossref_primary_10_1016_j_jogc_2016_05_011 crossref_primary_10_2471_BLT_18_208447 crossref_primary_10_1097_OGX_0000000000001224 crossref_primary_10_22374_cjgim_v13i3_199 crossref_primary_10_1007_s00404_023_07248_6 crossref_primary_10_1186_s12871_023_02174_1 crossref_primary_10_1136_bmjsem_2017_000242 crossref_primary_10_1093_aje_kwae214 crossref_primary_10_38136_jgon_820966 crossref_primary_10_1155_2021_6641023 crossref_primary_10_1371_journal_pmed_1003908 crossref_primary_10_18231_j_ijogr_2022_012 crossref_primary_10_1016_j_jogc_2016_04_002 crossref_primary_10_1055_s_0041_1728826 crossref_primary_10_3390_nu14163276 crossref_primary_10_1080_14767058_2020_1767059 crossref_primary_10_1177_1753495X18772999 crossref_primary_10_1016_j_preghy_2023_10_011 crossref_primary_10_1111_1471_0528_16602 crossref_primary_10_1111_jgh_13714 crossref_primary_10_1007_s40620_016_0285_6 crossref_primary_10_1016_j_jogc_2022_01_010 crossref_primary_10_1016_j_jelectrocard_2021_08_020 crossref_primary_10_1016_j_jogc_2017_07_025 crossref_primary_10_1007_s00431_025_06053_4 crossref_primary_10_1007_s40620_018_0499_x crossref_primary_10_1016_j_cjca_2015_12_011 crossref_primary_10_1213_ANE_0000000000006309 crossref_primary_10_1016_j_metabol_2019_154012 crossref_primary_10_3390_jcm11061576 crossref_primary_10_1161_HYPERTENSIONAHA_118_11320 crossref_primary_10_1007_s00134_015_3701_9 crossref_primary_10_1016_j_placenta_2020_07_032 crossref_primary_10_1002_bdr2_1796 crossref_primary_10_13181_mji_v25i2_1381 crossref_primary_10_1111_1471_0528_13569 crossref_primary_10_1016_j_jogn_2023_11_002 crossref_primary_10_1371_journal_pone_0281952 crossref_primary_10_1007_s12630_016_0689_8 crossref_primary_10_1038_s41371_021_00617_1 crossref_primary_10_1111_1471_0528_13568 crossref_primary_10_1161_HYPERTENSIONAHA_117_10803 crossref_primary_10_1016_j_cegh_2020_02_026 crossref_primary_10_1016_S0140_6736_19_31282_6 crossref_primary_10_15446_av_enferm_v38n1_81081 |
| Cites_doi | 10.1016/j.preghy.2013.03.001 10.1016/j.ajog.2008.03.011 10.1016/j.preghy.2014.01.003 10.1016/S0140-6736(10)61351-7 10.1136/bmj.38547.416493.06 10.1515/jpm.2011.098 10.1016/j.ajog.2004.12.035 10.1080/10641950801950197 10.1038/sj.ki.5001902 10.1111/j.1471-0528.1998.tb09971.x 10.1001/jama.282.15.1447 10.1016/j.ajog.2012.12.016 10.1016/S1701-2163(16)32776-1 10.1111/j.1471-0528.2004.00516.x 10.1016/j.ijgo.2004.03.009 10.1016/S0140-6736(11)60785-X 10.1016/S1701-2163(16)34907-6 10.3109/10641950109152635 10.1007/s12016-009-8191-5 10.1111/j.1471-0528.2005.00617.x 10.1016/j.ccl.2010.07.006 10.1016/S1701-2163(16)35215-X 10.1080/10641950802233072 10.1097/01.AOG.0000258281.22296.de 10.1016/j.autrev.2010.08.005 10.1081/CBI-120015963 10.1159/000341264 |
| ContentType | Journal Article |
| Contributor | Gruslin, Andrée Logan, Alexander G Audibert, Francois Leduc, Line Douglas, Myrtle Joanne Côté, Anne-Marie Bujold, Emmanuel Hutcheon, Jennifer Koren, Gideon Firoz, Tabassum Gibson, Paul Eastabrook, Genevieve Lange, Ian Magee, Laura A |
| Contributor_xml | – sequence: 1 givenname: Laura A surname: Magee fullname: Magee, Laura A – sequence: 2 givenname: Francois surname: Audibert fullname: Audibert, Francois – sequence: 3 givenname: Emmanuel surname: Bujold fullname: Bujold, Emmanuel – sequence: 4 givenname: Anne-Marie surname: Côté fullname: Côté, Anne-Marie – sequence: 5 givenname: Myrtle Joanne surname: Douglas fullname: Douglas, Myrtle Joanne – sequence: 6 givenname: Genevieve surname: Eastabrook fullname: Eastabrook, Genevieve – sequence: 7 givenname: Tabassum surname: Firoz fullname: Firoz, Tabassum – sequence: 8 givenname: Paul surname: Gibson fullname: Gibson, Paul – sequence: 9 givenname: Andrée surname: Gruslin fullname: Gruslin, Andrée – sequence: 10 givenname: Jennifer surname: Hutcheon fullname: Hutcheon, Jennifer – sequence: 11 givenname: Gideon surname: Koren fullname: Koren, Gideon – sequence: 12 givenname: Ian surname: Lange fullname: Lange, Ian – sequence: 13 givenname: Line surname: Leduc fullname: Leduc, Line – sequence: 14 givenname: Alexander G surname: Logan fullname: Logan, Alexander G |
| Copyright | 2014 Society of Obstetricians and Gynaecologists of Canada Society of Obstetricians and Gynaecologists of Canada |
| Copyright_xml | – notice: 2014 Society of Obstetricians and Gynaecologists of Canada – notice: Society of Obstetricians and Gynaecologists of Canada |
| CorporateAuthor | HYPERTENSION GUIDELINE COMMITTEE Canadian Hypertensive Disorders of Pregnancy Working Group |
| CorporateAuthor_xml | – name: HYPERTENSION GUIDELINE COMMITTEE – name: Canadian Hypertensive Disorders of Pregnancy Working Group |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/S1701-2163(15)30588-0 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EndPage | 438 |
| ExternalDocumentID | 24927294 10_1016_S1701_2163_15_30588_0 S1701216315305880 1_s2_0_S1701216315305880 |
| Genre | Journal Article Practice Guideline |
| GroupedDBID | .1- .FO 0R~ 1P~ 457 AALRI AAXUO ABJNI ACGFS AEVXI AFJKZ AFRHN AFTJW AGCQF AGHFR AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS APXCP EBS EFKBS EJD F5P FDB GX1 O9- OK1 OQ. PH~ ROL SJN Z5R AAIAV AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c455t-d74c9f61b46a76f916b045f17c41a27e3fcca45b50b63b2ec18f01b4fdeef8513 |
| ISSN | 1701-2163 |
| IngestDate | Fri Jul 11 14:08:18 EDT 2025 Wed Feb 19 02:40:05 EST 2025 Tue Jul 01 02:20:21 EDT 2025 Thu Apr 24 22:51:25 EDT 2025 Sat Apr 29 22:45:49 EDT 2023 Thu May 08 07:50:22 EDT 2025 Tue Aug 26 19:33:08 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | Hypertension blood pressure long-term prognosis pregnancy maternal outcome preeclampsia perinatal outcome hypertension |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c455t-d74c9f61b46a76f916b045f17c41a27e3fcca45b50b63b2ec18f01b4fdeef8513 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Instructional Material/Guideline-3 content type line 23 |
| PMID | 24927294 |
| PQID | 1536683762 |
| PQPubID | 23479 |
| PageCount | 23 |
| ParticipantIDs | proquest_miscellaneous_1536683762 pubmed_primary_24927294 crossref_citationtrail_10_1016_S1701_2163_15_30588_0 crossref_primary_10_1016_S1701_2163_15_30588_0 elsevier_sciencedirect_doi_10_1016_S1701_2163_15_30588_0 elsevier_clinicalkeyesjournals_1_s2_0_S1701216315305880 elsevier_clinicalkey_doi_10_1016_S1701_2163_15_30588_0 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-May |
| PublicationDateYYYYMMDD | 2014-05-01 |
| PublicationDate_xml | – month: 05 year: 2014 text: 2014-May |
| PublicationDecade | 2010 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Journal of obstetrics and gynaecology Canada |
| PublicationTitleAlternate | J Obstet Gynaecol Can |
| PublicationYear | 2014 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Stutchfield, Whitaker, Russell, Antenatal Steroids for Term Elective Caesarean Section (ASTECS) (bb0180) 2005; 331 Mouthon, Berezne, Bussone, Noel, Villiger, Guillevin (bb0155) 2011; 40 Urquia, Ying, Glazier, Berger, De Souza, Ray (bb0065) 2012; 34 Erkan, Espinosa, Cervera (bb0145) 2010; 10 Ogge, Chaiworapongsa, Romero, Hussein, Kusanovic, Yeo (bb0160) 2011; 39 Magee, Pels, Helewa, Rey, Von Dadelszen, Canadian Hypertensive Disorders of Pregnancy (HDP) Working Group (bb0015) 2014 Roberts (bb0185) 2010 Sibai (bb0135) 2007; 109 Brown, Mangos, Davis, Homer (bb0095) 2005; 112 Redman (bb0025) 1993 Eguchi, Akihide, Takako, Chikako, Kayo (bb0130) 2012; 14 Martin, Bailey, Rehberg, Owens, Keiser, May (bb0150) 2008; 199 Payne, Magee, Menzies, Cote, Hutcheon, Kyle (bb0035) 2011; 33 Akolekar, Syngelaki, Poon, Wright, Nicolaides (bb0165) 2013; 33 Kaur, Picconi, Chadha, Kruger, Mari (bb0055) 2008; 199 Saudan, Brown, Buddle, Jones (bb0105) 1998; 105 Shennan, Redman, Cooper, Milne (bb0190) 2012; 379 Villar, Say, Shennan, Lindheimer, Duley, Conde-Agudelo (bb0115) 2004; 85 Gruslin, Lemyre (bb0045) 2011; 25 Magee, Ramsay, von Dadelszen (bb0100) 2008; 27 Reinders, Cuckson, Lee, Shennan (bb0110) 2005; 112 von Dadelszen, Payne, Li, Ansermino, Broughton Pipkin, Côté (bb0030) 2011; 377 Why mothers die 2000–2002 (bb0085) 2004 Rey, Morin, Boudreault, Pilon, Vincent, Ouellet (bb0090) 2009; 28 Scazzocchio, Figueras, Crispi, Meler, Masoller, Mula (bb0170) 2013; 208 Bellomo, Narducci, Rondoni, Pastorelli, Stangoni, Angeli (bb0120) 1999; 282 Lampinen, Ronnback, Groop, Kaaja (bb0040) 2006; 70 American College of Obstetricians and Gynecologists (bb0075) 2013; 122 Fesenmeier, Coppage, Lambers, Barton, Sibai (bb0140) 2005; 192 Brown, Lindheimer, de Swiet, Van Assche, Moutquin (bb0080) 2001; 20 Lalor, Fawole, Alfirevic, Devane (bb0050) 2008; 1 Hermida, Ayala, Iglesias (bb0125) 2003; 20 Health Canada (bb0005) 2004 Magee, Helewa, Moutquin, von Dadelszen, Hypertension Guideline Committee (bb0070) 2008; 30 Payne, Kyle, Lim, Lisonkova, Magee, Pullar (bb0060) 2013; 3 Ogedegbe, Pickering (bb0020) 2010; 28 Woolf, Battista, Angerson, Logan, Eel (bb0195) 2003; 169 Centre for Maternal and Child Enquiries (bb0010) 2011; 118 Roberts, Dalziel (bb0175) 2006; 3 Ogge (10.1016/S1701-2163(15)30588-0_bb0160) 2011; 39 Brown (10.1016/S1701-2163(15)30588-0_bb0080) 2001; 20 Stutchfield (10.1016/S1701-2163(15)30588-0_bb0180) 2005; 331 Roberts (10.1016/S1701-2163(15)30588-0_bb0185) 2010 Brown (10.1016/S1701-2163(15)30588-0_bb0095) 2005; 112 Martin (10.1016/S1701-2163(15)30588-0_bb0150) 2008; 199 Magee (10.1016/S1701-2163(15)30588-0_bb0015) 2014 Lalor (10.1016/S1701-2163(15)30588-0_bb0050) 2008; 1 Payne (10.1016/S1701-2163(15)30588-0_bb0060) 2013; 3 Reinders (10.1016/S1701-2163(15)30588-0_bb0110) 2005; 112 Bellomo (10.1016/S1701-2163(15)30588-0_bb0120) 1999; 282 Fesenmeier (10.1016/S1701-2163(15)30588-0_bb0140) 2005; 192 Kaur (10.1016/S1701-2163(15)30588-0_bb0055) 2008; 199 Magee (10.1016/S1701-2163(15)30588-0_bb0070) 2008; 30 Saudan (10.1016/S1701-2163(15)30588-0_bb0105) 1998; 105 Redman (10.1016/S1701-2163(15)30588-0_bb0025) 1993 Mouthon (10.1016/S1701-2163(15)30588-0_bb0155) 2011; 40 Why mothers die 2000–2002 (10.1016/S1701-2163(15)30588-0_bb0085) 2004 Villar (10.1016/S1701-2163(15)30588-0_bb0115) 2004; 85 von Dadelszen (10.1016/S1701-2163(15)30588-0_bb0030) 2011; 377 Magee (10.1016/S1701-2163(15)30588-0_bb0100) 2008; 27 Woolf (10.1016/S1701-2163(15)30588-0_bb0195) 2003; 169 Erkan (10.1016/S1701-2163(15)30588-0_bb0145) 2010; 10 Roberts (10.1016/S1701-2163(15)30588-0_bb0175) 2006; 3 Health Canada (10.1016/S1701-2163(15)30588-0_bb0005) 2004 Rey (10.1016/S1701-2163(15)30588-0_bb0090) 2009; 28 Centre for Maternal and Child Enquiries (10.1016/S1701-2163(15)30588-0_bb0010) 2011; 118 Hermida (10.1016/S1701-2163(15)30588-0_bb0125) 2003; 20 Shennan (10.1016/S1701-2163(15)30588-0_bb0190) 2012; 379 Payne (10.1016/S1701-2163(15)30588-0_bb0035) 2011; 33 Eguchi (10.1016/S1701-2163(15)30588-0_bb0130) 2012; 14 American College of Obstetricians and Gynecologists (10.1016/S1701-2163(15)30588-0_bb0075) 2013; 122 Urquia (10.1016/S1701-2163(15)30588-0_bb0065) 2012; 34 Akolekar (10.1016/S1701-2163(15)30588-0_bb0165) 2013; 33 Sibai (10.1016/S1701-2163(15)30588-0_bb0135) 2007; 109 Lampinen (10.1016/S1701-2163(15)30588-0_bb0040) 2006; 70 Gruslin (10.1016/S1701-2163(15)30588-0_bb0045) 2011; 25 Scazzocchio (10.1016/S1701-2163(15)30588-0_bb0170) 2013; 208 Ogedegbe (10.1016/S1701-2163(15)30588-0_bb0020) 2010; 28 |
| References_xml | – volume: 122 start-page: 1122 year: 2013 end-page: 1131 ident: bb0075 article-title: Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy publication-title: Obstet Gynecol – volume: 85 start-page: S28 year: 2004 end-page: S41 ident: bb0115 article-title: Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of pre-eclampsia and eclampsia publication-title: Int J Gynaecol Obstet – volume: 377 start-page: 219 year: 2011 end-page: 227 ident: bb0030 article-title: PIERS Study Group. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model publication-title: Lancet – volume: 20 start-page: IX year: 2001 end-page: XIV ident: bb0080 article-title: The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) publication-title: Hypertens Pregnancy – volume: 199 start-page: 98 year: 2008 end-page: 104 ident: bb0150 article-title: Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955–2006 publication-title: Am J Obstet Gynecol – volume: 10 start-page: 74 year: 2010 end-page: 79 ident: bb0145 article-title: Catastrophic antiphospholipid syndrome: updated diagnostic algorithms publication-title: Autoimmun Rev – volume: 33 start-page: 8 year: 2013 end-page: 15 ident: bb0165 article-title: Competing risks model in early screening for preeclampsia by biophysical and biochemical markers publication-title: Fetal Diagn Ther – volume: 282 start-page: 1447 year: 1999 end-page: 1452 ident: bb0120 article-title: Prognostic value of 24-hour blood pressure in pregnancy publication-title: JAMA – volume: 208 start-page: 203.e1 year: 2013 end-page: 203.e10 ident: bb0170 article-title: Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting publication-title: Am J Obstet Gynecol – year: 2014 ident: bb0015 article-title: Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy publication-title: Pregnancy Hypertens – volume: 1 start-page: CD000038 year: 2008 ident: bb0050 article-title: Biophysical profile for fetal assessment in high risk pregnancies publication-title: Cochrane Database Syst Rev. – volume: 40 start-page: 84 year: 2011 end-page: 91 ident: bb0155 article-title: Scleroderma renal crisis: a rare but severe complication of systemic sclerosis publication-title: Clin Rev Allergy Immunol – volume: 14 year: 2012 ident: bb0130 article-title: abstracts of American Society of Hypertension 27th Annual Scientific Meeting and Exposition publication-title: J Clin Hypertens – volume: 109 start-page: 956 year: 2007 end-page: 966 ident: bb0135 article-title: Imitators of severe preeclampsia publication-title: Obstet Gynecol – volume: 169 start-page: 207 year: 2003 end-page: 208 ident: bb0195 article-title: Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care publication-title: CMAJ – volume: 3 start-page: CD004454 year: 2006 ident: bb0175 article-title: Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth publication-title: Cochrane Database of Systematic Reviews – start-page: 433 year: 1993 end-page: 467 ident: bb0025 article-title: The placenta, pre-eclampsia and chronic villitis publication-title: The human placenta – volume: 3 start-page: 166 year: 2013 end-page: 171 ident: bb0060 article-title: An assessment of predictive value of the biophysical profile in women with preeclampsia using data from the full PIERS database publication-title: Pregnancy Hypertens – volume: 30 start-page: S1 year: 2008 end-page: S48 ident: bb0070 article-title: Strategic Training Initiative in Research in the Reproductive Health Sciences (STIRRHS) Scholars. SOGC Clinical Practice Guidelines, No. 206, March 2008. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy publication-title: J Obstet Gynaecol Can – volume: 379 start-page: 1686 year: 2012 end-page: 1687 ident: bb0190 article-title: Are most maternal deaths from pre-eclampsia avoidable? publication-title: Lancet – volume: 199 start-page: e1 year: 2008 end-page: e4 ident: bb0055 article-title: Biophysical profile in the treatment of intrauterine growth-restricted fetuses who weigh < publication-title: Am J Obstet Gynecol – volume: 192 start-page: 1416 year: 2005 end-page: 1419 ident: bb0140 article-title: Acute fatty liver of pregnancy in 3 tertiary care centers publication-title: Am J Obstet Gynecol – year: 2004 ident: bb0085 article-title: The sixth report of the Confidential Enquiries into Maternal Deaths in the United Kingdom – volume: 112 start-page: 915 year: 2005 end-page: 920 ident: bb0110 article-title: An accurate automated blood pressure device for use in pregnancy and pre-eclampsia: the Microlife 3BTO-A publication-title: BJOG – volume: 28 start-page: 571 year: 2010 end-page: 586 ident: bb0020 article-title: Principles and techniques of blood pressure measurement publication-title: Cardio Clin – volume: 27 start-page: 95 year: 2008 end-page: 101 ident: bb0100 article-title: What is the role of out-ofoffice BP measurement in hypertensive pregnancy? publication-title: Hypertens Pregnancy – volume: 118 start-page: 1 year: 2011 end-page: 203 ident: bb0010 article-title: Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006–08. The eighth report on confidential enquiries into maternal deaths in the United Kingdom publication-title: BJOG – volume: 33 start-page: 588 year: 2011 end-page: 597 ident: bb0035 article-title: PIERS Study Group. PIERS proteinuria: relationship with adverse maternal and perinatal outcome publication-title: J Obstet Gynaecol Can – volume: 28 start-page: 168 year: 2009 end-page: 177 ident: bb0090 article-title: Blood pressure assessments in different subtypes of hypertensive pregnant women: office versus home patient- or nurse-measured blood pressure publication-title: Hypertens Pregnancy – volume: 20 start-page: 135 year: 2003 end-page: 156 ident: bb0125 article-title: Circadian rhythm of blood pressure challenges office values as the “gold standard” in the diagnosis of gestational hypertension publication-title: Chronobiol Int – volume: 331 start-page: 662 year: 2005 ident: bb0180 article-title: Research Team. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial publication-title: BMJ – volume: 25 start-page: 401 year: 2011 end-page: 507 ident: bb0045 article-title: Pre-eclampsia: fetal assessment and neonatal outcomes publication-title: Best Pract Res Clinl Obstet Gynaecol – volume: 112 start-page: 601 year: 2005 end-page: 606 ident: bb0095 article-title: The natural history of white coat hypertension during pregnancy publication-title: BJOG – volume: 105 start-page: 1177 year: 1998 end-page: 1184 ident: bb0105 article-title: Does gestational hypertension become pre-eclampsia? publication-title: Br J Obstet Gynaecol – volume: 34 start-page: 348 year: 2012 end-page: 352 ident: bb0065 article-title: Serious preeclampsia among different immigrant groups publication-title: J Obstet Gynaecol Can – volume: 39 start-page: 641 year: 2011 end-page: 652 ident: bb0160 article-title: Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia publication-title: J Perinat Med – year: 2004 ident: bb0005 article-title: Special report on maternal mortality and severe morbidity in Canada. Enhanced surveillance: the path to prevention – volume: 70 start-page: 1818 year: 2006 end-page: 1822 ident: bb0040 article-title: Renal and vascular function in women with previous preeclampsia: a comparison of low- and high-degree proteinuria publication-title: Kidney Int – year: 2010 ident: bb0185 article-title: Royal College of Obstetricians and Gynaecologists publication-title: Antenatal corticosteroids to reduce neonatal morbidity and mortality. Green-top Guideline No. 7 – volume: 3 start-page: 166 year: 2013 ident: 10.1016/S1701-2163(15)30588-0_bb0060 article-title: An assessment of predictive value of the biophysical profile in women with preeclampsia using data from the full PIERS database publication-title: Pregnancy Hypertens doi: 10.1016/j.preghy.2013.03.001 – volume: 199 start-page: 98 year: 2008 ident: 10.1016/S1701-2163(15)30588-0_bb0150 article-title: Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955–2006 publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2008.03.011 – year: 2014 ident: 10.1016/S1701-2163(15)30588-0_bb0015 article-title: Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy publication-title: Pregnancy Hypertens doi: 10.1016/j.preghy.2014.01.003 – volume: 377 start-page: 219 issue: 9761 year: 2011 ident: 10.1016/S1701-2163(15)30588-0_bb0030 article-title: PIERS Study Group. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model publication-title: Lancet doi: 10.1016/S0140-6736(10)61351-7 – volume: 331 start-page: 662 year: 2005 ident: 10.1016/S1701-2163(15)30588-0_bb0180 article-title: Research Team. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial publication-title: BMJ doi: 10.1136/bmj.38547.416493.06 – volume: 39 start-page: 641 year: 2011 ident: 10.1016/S1701-2163(15)30588-0_bb0160 article-title: Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia publication-title: J Perinat Med doi: 10.1515/jpm.2011.098 – volume: 192 start-page: 1416 year: 2005 ident: 10.1016/S1701-2163(15)30588-0_bb0140 article-title: Acute fatty liver of pregnancy in 3 tertiary care centers publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2004.12.035 – volume: 27 start-page: 95 year: 2008 ident: 10.1016/S1701-2163(15)30588-0_bb0100 article-title: What is the role of out-ofoffice BP measurement in hypertensive pregnancy? publication-title: Hypertens Pregnancy doi: 10.1080/10641950801950197 – volume: 14 issue: Suppl 1 year: 2012 ident: 10.1016/S1701-2163(15)30588-0_bb0130 article-title: abstracts of American Society of Hypertension 27th Annual Scientific Meeting and Exposition publication-title: J Clin Hypertens – start-page: 433 year: 1993 ident: 10.1016/S1701-2163(15)30588-0_bb0025 article-title: The placenta, pre-eclampsia and chronic villitis – volume: 70 start-page: 1818 year: 2006 ident: 10.1016/S1701-2163(15)30588-0_bb0040 article-title: Renal and vascular function in women with previous preeclampsia: a comparison of low- and high-degree proteinuria publication-title: Kidney Int doi: 10.1038/sj.ki.5001902 – volume: 105 start-page: 1177 year: 1998 ident: 10.1016/S1701-2163(15)30588-0_bb0105 article-title: Does gestational hypertension become pre-eclampsia? publication-title: Br J Obstet Gynaecol doi: 10.1111/j.1471-0528.1998.tb09971.x – volume: 282 start-page: 1447 year: 1999 ident: 10.1016/S1701-2163(15)30588-0_bb0120 article-title: Prognostic value of 24-hour blood pressure in pregnancy publication-title: JAMA doi: 10.1001/jama.282.15.1447 – volume: 208 start-page: 203.e1 issue: 3 year: 2013 ident: 10.1016/S1701-2163(15)30588-0_bb0170 article-title: Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2012.12.016 – volume: 30 start-page: S1 issue: 3 Suppl 1 year: 2008 ident: 10.1016/S1701-2163(15)30588-0_bb0070 article-title: Strategic Training Initiative in Research in the Reproductive Health Sciences (STIRRHS) Scholars. SOGC Clinical Practice Guidelines, No. 206, March 2008. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy publication-title: J Obstet Gynaecol Can doi: 10.1016/S1701-2163(16)32776-1 – year: 2010 ident: 10.1016/S1701-2163(15)30588-0_bb0185 article-title: Royal College of Obstetricians and Gynaecologists – volume: 112 start-page: 601 year: 2005 ident: 10.1016/S1701-2163(15)30588-0_bb0095 article-title: The natural history of white coat hypertension during pregnancy publication-title: BJOG doi: 10.1111/j.1471-0528.2004.00516.x – volume: 85 start-page: S28 issue: Suppl 1 year: 2004 ident: 10.1016/S1701-2163(15)30588-0_bb0115 article-title: Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of pre-eclampsia and eclampsia publication-title: Int J Gynaecol Obstet doi: 10.1016/j.ijgo.2004.03.009 – volume: 169 start-page: 207 year: 2003 ident: 10.1016/S1701-2163(15)30588-0_bb0195 article-title: Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care publication-title: CMAJ – volume: 122 start-page: 1122 year: 2013 ident: 10.1016/S1701-2163(15)30588-0_bb0075 article-title: Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy publication-title: Obstet Gynecol – volume: 379 start-page: 1686 issue: 9827 year: 2012 ident: 10.1016/S1701-2163(15)30588-0_bb0190 article-title: Are most maternal deaths from pre-eclampsia avoidable? publication-title: Lancet doi: 10.1016/S0140-6736(11)60785-X – volume: 3 start-page: CD004454 year: 2006 ident: 10.1016/S1701-2163(15)30588-0_bb0175 article-title: Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth publication-title: Cochrane Database of Systematic Reviews – volume: 118 start-page: 1 issue: Suppl 1 year: 2011 ident: 10.1016/S1701-2163(15)30588-0_bb0010 article-title: Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006–08. The eighth report on confidential enquiries into maternal deaths in the United Kingdom publication-title: BJOG – year: 2004 ident: 10.1016/S1701-2163(15)30588-0_bb0005 – volume: 33 start-page: 588 year: 2011 ident: 10.1016/S1701-2163(15)30588-0_bb0035 article-title: PIERS Study Group. PIERS proteinuria: relationship with adverse maternal and perinatal outcome publication-title: J Obstet Gynaecol Can doi: 10.1016/S1701-2163(16)34907-6 – volume: 20 start-page: IX issue: 1 year: 2001 ident: 10.1016/S1701-2163(15)30588-0_bb0080 article-title: The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) publication-title: Hypertens Pregnancy doi: 10.3109/10641950109152635 – volume: 40 start-page: 84 year: 2011 ident: 10.1016/S1701-2163(15)30588-0_bb0155 article-title: Scleroderma renal crisis: a rare but severe complication of systemic sclerosis publication-title: Clin Rev Allergy Immunol doi: 10.1007/s12016-009-8191-5 – volume: 112 start-page: 915 year: 2005 ident: 10.1016/S1701-2163(15)30588-0_bb0110 article-title: An accurate automated blood pressure device for use in pregnancy and pre-eclampsia: the Microlife 3BTO-A publication-title: BJOG doi: 10.1111/j.1471-0528.2005.00617.x – volume: 28 start-page: 571 year: 2010 ident: 10.1016/S1701-2163(15)30588-0_bb0020 article-title: Principles and techniques of blood pressure measurement publication-title: Cardio Clin doi: 10.1016/j.ccl.2010.07.006 – volume: 34 start-page: 348 year: 2012 ident: 10.1016/S1701-2163(15)30588-0_bb0065 article-title: Serious preeclampsia among different immigrant groups publication-title: J Obstet Gynaecol Can doi: 10.1016/S1701-2163(16)35215-X – volume: 28 start-page: 168 year: 2009 ident: 10.1016/S1701-2163(15)30588-0_bb0090 article-title: Blood pressure assessments in different subtypes of hypertensive pregnant women: office versus home patient- or nurse-measured blood pressure publication-title: Hypertens Pregnancy doi: 10.1080/10641950802233072 – volume: 25 start-page: 401 year: 2011 ident: 10.1016/S1701-2163(15)30588-0_bb0045 article-title: Pre-eclampsia: fetal assessment and neonatal outcomes publication-title: Best Pract Res Clinl Obstet Gynaecol – volume: 109 start-page: 956 year: 2007 ident: 10.1016/S1701-2163(15)30588-0_bb0135 article-title: Imitators of severe preeclampsia publication-title: Obstet Gynecol doi: 10.1097/01.AOG.0000258281.22296.de – volume: 10 start-page: 74 year: 2010 ident: 10.1016/S1701-2163(15)30588-0_bb0145 article-title: Catastrophic antiphospholipid syndrome: updated diagnostic algorithms publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2010.08.005 – volume: 199 start-page: e1 issue: 264 year: 2008 ident: 10.1016/S1701-2163(15)30588-0_bb0055 article-title: Biophysical profile in the treatment of intrauterine growth-restricted fetuses who weigh <1000g publication-title: Am J Obstet Gynecol – volume: 1 start-page: CD000038 year: 2008 ident: 10.1016/S1701-2163(15)30588-0_bb0050 article-title: Biophysical profile for fetal assessment in high risk pregnancies publication-title: Cochrane Database Syst Rev. – year: 2004 ident: 10.1016/S1701-2163(15)30588-0_bb0085 – volume: 20 start-page: 135 year: 2003 ident: 10.1016/S1701-2163(15)30588-0_bb0125 article-title: Circadian rhythm of blood pressure challenges office values as the “gold standard” in the diagnosis of gestational hypertension publication-title: Chronobiol Int doi: 10.1081/CBI-120015963 – volume: 33 start-page: 8 year: 2013 ident: 10.1016/S1701-2163(15)30588-0_bb0165 article-title: Competing risks model in early screening for preeclampsia by biophysical and biochemical markers publication-title: Fetal Diagn Ther doi: 10.1159/000341264 |
| SSID | ssj0057379 |
| Score | 2.5290568 |
| Snippet | This executive summary presents in brief the current evidence assessed in the clinical practice guideline prepared by the Canadian Hypertensive Disorders of... Abstract Objective This executive summary presents in brief the current evidence assessed in the clinical practice guideline prepared by the Canadian... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 416 |
| SubjectTerms | blood pressure Female Humans Hypertension Hypertension, Pregnancy-Induced - diagnosis Hypertension, Pregnancy-Induced - therapy long-term prognosis maternal outcome Obstetrics and Gynecology perinatal outcome preeclampsia Pregnancy |
| Title | Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1701216315305880 https://www.clinicalkey.es/playcontent/1-s2.0-S1701216315305880 https://dx.doi.org/10.1016/S1701-2163(15)30588-0 https://www.ncbi.nlm.nih.gov/pubmed/24927294 https://www.proquest.com/docview/1536683762 |
| Volume | 36 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXKkBAviG86PmQkkEAsXZzYTsbbBEUVUnnZJvXNsl17L1WC2oYx_gh_l-vYcQrrtLE-RFVqx5Xvie-9zrknCL2BLGKuIZBPSsZUQomhyQFL80TCR5dWFrKt4p9-45MT-nXGZoPB7w3WUrNWI_1ra13JTawK58Curkr2PywbLwon4DvYF45gYThey8afPU_OywSMo253x8jsqS0dE2ACWeey46x3wpueB7c0p057oxWAGv80umk5RUehtm17CFsrwIiT-PdCz6fnlTTaizq1qgdxyZ_C_zBdGbb8cDjqV-SFfx1yVTexZsi5wjP5L6nfPRXy--vjH2ZxHugAYcOC0J4e6HfRukqav4ieThY-yUhY7MLK7KVRAgLZxjJLCd_w2NTrw1xwBn5f4ihe2ilfsbcQ36QMgJT2HjDyEtu2rin4AdcovYVuZ5B_tFXks8gdYoUXcYxX7kvD9vvh3hH2Pgx1WdBzWVLTBjfH99G9YFJ86CH2AA1M9RDdmQbexSOkI9L2cI-zPQxWxz3KcG0xoAxvogxHlLlfI8o-4ogxHDD2GJ18GR9_miTh9RyJpoytk3lB9YHlRFEuC24hz1CQH1hSaEpkVpjcwupAmWKp4rnKjCalTaG1nRtjIdDPn6Cdqq7MM4SdxJTVClJvqam2RCpT0tzkCgbiKbVDRLv5Ezpo17tXqCxEJCm6aRdu2gVhop12kQ7RKHb77sVbrurAO-OIrjIZfKkARF3VsdjW0azCarESRKwykYoLCBuiMvYMQa8PZq8z6OsOPwKcgnvSJytTNzAYyzkvIXbIhuipB1acACcRChk13b35wM_R3f7GfoF21svGvITYfK1etffJHyIA2zo |
| linkProvider | Geneva Foundation for Medical Education and Research |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnosis%2C+Evaluation%2C+and+Management+of+the+Hypertensive+Disorders+of+Pregnancy%3A+Executive+Summary&rft.jtitle=Journal+of+obstetrics+and+gynaecology+Canada&rft.au=Magee%2C+Laura+A.&rft.au=Pels%2C+Anouk&rft.au=Helewa%2C+Michael&rft.au=Rey%2C+Evelyne&rft.date=2014-05-01&rft.pub=Elsevier+Inc&rft.issn=1701-2163&rft.volume=36&rft.issue=5&rft.spage=416&rft.epage=438&rft_id=info:doi/10.1016%2FS1701-2163%2815%2930588-0&rft.externalDocID=S1701216315305880 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F17012163%2FS1701216314X6500X%2Fcov150h.gif |